The US pharmaceutical company Johnson & Johnson will begin delivering vaccines to European countries on April 19. The company announced on Monday. The Johnson & Johnson vaccine received the green light from Brussels for use in the EU on March 11th. It is the fourth corona vaccine after the vaccines from Biontech / Pfizer, Moderna and Astrazeneca, which has EU-wide approval. </p><div> <p>To expand its production, the US company had signed several cooperation agreements with European companies in the past few months, including IDT Biologika, a company from Dessau. Johnson & Johnson also works with Sanofi in France and Catalent in Italy.</p>
The US company’s vaccine is currently being used in the USA and South Africa, and approval has also been granted for Canada. According to the company, the J&J vaccine, which unlike the other vaccines only has to be administered once, also protects against mutants of the coronavirus.
A worldwide study with almost 40,000 participants had shown an effectiveness of 85.4 percent against severe courses of Covid-19, the effectiveness with moderate courses was a good 66 percent. In contrast to competing products, the vaccine does not have to be cooled as much, which makes transport and distribution easier.